These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1282812)

  • 1. Modulation of trichosanthin antigenicity by coupling to dextran.
    Ko WH; Wong CC; Yeung HW; Tam SC
    Biochem Int; 1992 Dec; 28(4):643-50. PubMed ID: 1282812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The biological activities of trichosanthin after coupling to dextran.
    Ko WH; Yeung HW; Tam SC
    Gen Pharmacol; 1993 May; 24(3):757-62. PubMed ID: 7690000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lowering of trichosanthin immunogenicity by site-specific coupling to dextran.
    Chan WL; Shaw PC; Li XB; Xu QF; He XH; Tam SC
    Biochem Pharmacol; 1999 Apr; 57(8):927-34. PubMed ID: 10086327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-directed polyethylene glycol modification of trichosanthin: effects on its biological activities, pharmacokinetics, and antigenicity.
    He XH; Shaw PC; Xu LH; Tam SC
    Life Sci; 1999; 64(14):1163-75. PubMed ID: 10210259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Y55 and D78 are crucial amino acid residues of a new IgE epitope on trichosanthin.
    Zhang XY; Wu Y; Yan JY; Gao Y; Wang Y; Mi SL; An CC
    Biochem Biophys Res Commun; 2006 May; 343(4):1251-6. PubMed ID: 16581017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapping the antigenic determinants and reducing the immunogenicity of trichosanthin by site-directed mutagenesis.
    An Q; Wei S; Mu S; Zhang X; Lei Y; Zhang W; Jia N; Cheng X; Fan A; Li Z; Xu Z
    J Biomed Sci; 2006 Sep; 13(5):637-43. PubMed ID: 16977428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing the immunogenicity and improving the in vivo activity of trichosanthin by site-directed pegylation.
    He XH; Shaw PC; Tam SC
    Life Sci; 1999; 65(4):355-68. PubMed ID: 10421422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of site-directed PEGylation of trichosanthin on its biological activity, immunogenicity, and pharmacokinetics.
    An Q; Lei Y; Jia N; Zhang X; Bai Y; Yi J; Chen R; Xia A; Yang J; Wei S; Cheng X; Fan A; Mu S; Xu Z
    Biomol Eng; 2007 Dec; 24(6):643-9. PubMed ID: 18023612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increasing the plasma half-life of trichosanthin by coupling to dextran.
    Ko WH; Wong CC; Yeung HW; Yung MH; Shaw PC; Tam SC
    Biochem Pharmacol; 1991 Oct; 42(9):1721-8. PubMed ID: 1718284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of IgE antibody response to trichosanthin alpha-momorcharin and beta-momorcharin in mice.
    Zheng SS; Wai WL; Hin WY; Wu AR
    Chin Med J (Engl); 1991 Apr; 104(4):292-9. PubMed ID: 2065546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro.
    Wang JH; Tam SC; Huang H; Ouyang DY; Wang YY; Zheng YT
    Biochem Biophys Res Commun; 2004 May; 317(4):965-71. PubMed ID: 15094363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of IL-4 and other factors in the trichosanthin-induced ovalbumin-specific IgE response.
    Xu WF; Ji YY; Wu YD; Lin GM; Ye M; Sun B
    Acta Pharmacol Sin; 2001 Aug; 22(8):736-40. PubMed ID: 11749848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel IgE peptide-based vaccine prevents the increase of IgE and down-regulates elevated IgE in rodents.
    Peng Z; Liu Q; Wang Q; Rector E; Ma Y; Warrington R
    Clin Exp Allergy; 2007 Jul; 37(7):1040-8. PubMed ID: 17581197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Th1- and enhancement of Th2-initiating cytokines and chemokines in trichosanthin- treated macrophages.
    Xu W; Hou W; Yao G; Ji Y; Yeh M; Sun B
    Biochem Biophys Res Commun; 2001 Jun; 284(1):168-72. PubMed ID: 11374886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of epitopes of trichosanthin by phage peptide library.
    Zhu Z; Ming Y; Sun B
    Biochem Biophys Res Commun; 2001 Apr; 282(4):921-7. PubMed ID: 11352639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Position 120-123, a potential active site of trichosanthin.
    Nie H; Cai X; He X; Xu L; Ke X; Ke Y; Tam SC
    Life Sci; 1998; 62(6):491-500. PubMed ID: 9464461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural analysis and molecular modeling of two anti-trichosanthin IgE clones from phage antibody library.
    Li ZD; Yuan YR; Yeh M
    Cell Res; 1997 Dec; 7(2):171-8. PubMed ID: 9444396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the amino acid residues in trichosanthin crucial for IgE response.
    Cai X; Yao G; Xu G; Yang C; Xu H; Lin Y; Yu J; Sun B
    Biochem Biophys Res Commun; 2002 Sep; 297(3):510-6. PubMed ID: 12270124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in trichosanthin, a ribosome-inactivating protein with multiple pharmacological properties.
    Shaw PC; Lee KM; Wong KB
    Toxicon; 2005 May; 45(6):683-9. PubMed ID: 15804517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal reabsorption of trichosanthin and the effect on GFR.
    Ko WH; Tam SC
    Ren Fail; 1994; 16(3):359-66. PubMed ID: 8059019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.